|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12...2728293031323334353637...3940» |
- Trial completion: Brief Intervention to Reduce Injury in Minorities (clinicaltrials.gov) - Jan 28, 2013
P=N/A, N=1493, Completed, Sponsor: The University of Texas Health Science Center, Houston
Active, not recruiting --> Completed
- naltrexone / Generic mfg., memantine / Generic mfg.
Trial initiation date: NAMHS-1: Memantine and Naltrexone Treatment for Opioid Dependence (clinicaltrials.gov) - Jan 27, 2013
P2, N=81, Completed, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed Initiation date: Jul 1999 --> Jun 2005
- | New P2 trial: Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers (clinicaltrials.gov) - Jan 27, 2013
P2, N=124, Recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- lorazepam / Generic mfg., disulfiram / Generic mfg.
Trial completion: Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder (clinicaltrials.gov) - Jan 27, 2013
P4, N=45, Completed, Sponsor: University of New Mexico
Initiation date: Jul 1999 --> Jun 2005 Recruiting --> Completed
- Enrollment closed: GMI-IHMDs: Impact of Group Motivational Interviewing and In-Home-Messaging-Devices for Dually Diagnosed Veterans (clinicaltrials.gov) - Jan 23, 2013
P0, N=180, Active, not recruiting, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Pharmacotherapy and Mechanisms of Sleep Disturbance in Alcohol Dependence (clinicaltrials.gov) - Jan 22, 2013
P=N/A, N=59, Completed, Sponsor: Dr. Kirk Brower
Recruiting --> Active, not recruiting Recruiting --> Completed
- atomoxetine / Generic mfg.
Trial completion: Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1 (clinicaltrials.gov) - Jan 22, 2013
P1, N=16, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed Active, not recruiting --> Completed
- Chantix (varenicline) / Pfizer
Enrollment change: Pilot Study of Varenicline to Treat Opioid Dependence (clinicaltrials.gov) - Jan 21, 2013
P1, N=21, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed N=40 --> 21
- | Chantix (varenicline) / Pfizer
Trial completion: Pilot Study of Varenicline to Treat Opioid Dependence (clinicaltrials.gov) - Jan 21, 2013
P1, N=21, Completed, Sponsor: Mayo Clinic
N=40 --> 21 Recruiting --> Completed
- bupropion sustained-release / Generic mfg.
New P1 trial: Influence of Bupropion on the Effects of MDMA (clinicaltrials.gov) - Jan 16, 2013
P1, N=16, Completed, Sponsor: University Hospital, Basel, Switzerland
- Enrollment change: Post-traumatic Stress Disorder (PTSD), Addiction, and Virtual Reality (clinicaltrials.gov) - Jan 14, 2013
P=N/A, N=60, Active, not recruiting, Sponsor: Duke University
Recruiting --> Completed N=100 --> 60
- dutasteride capsule / Generic mfg.
Enrollment open: Dutasteride Treatment for the Reduction of Heavy Drinking in Men (clinicaltrials.gov) - Jan 14, 2013
P4, N=160, Recruiting, Sponsor: University of Connecticut Health Center
N=100 --> 60 Not yet recruiting --> Recruiting
- | Lucemyra (lofexidine) / US WorldMeds, Stada
Trial completion: Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients (clinicaltrials.gov) - Jan 14, 2013
P1, N=27, Completed, Sponsor: US WorldMeds LLC
Not yet recruiting --> Recruiting Recruiting --> Completed
- | topiramate / Generic mfg.
New P2 trial: Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers (clinicaltrials.gov) - Jan 7, 2013
P2, N=60, Active, not recruiting, Sponsor: University of Pennsylvania
- morphine sulphate / Generic mfg.
Enrollment open: Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS) (clinicaltrials.gov) - Jan 7, 2013
P2, N=64, Enrolling by invitation, Sponsor: Pediatrix Medical Group
Recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- ||||| Trial initiation date: Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure (clinicaltrials.gov) - Jan 6, 2013
P3, N=200, Recruiting, Sponsor: Vital Therapies, Inc.
Not yet recruiting --> Enrolling by invitation Initiation date: Oct 2012 --> Feb 2013
- naltrexone / Generic mfg.
Trial completion: Naltrexone Treatment of Alcohol Abuse in Schizophrenia (clinicaltrials.gov) - Jan 6, 2013
P4, N=90, Completed, Sponsor: State University of New York - Upstate Medical University
Initiation date: Oct 2012 --> Feb 2013 Active, not recruiting --> Completed
- baclofen / Generic mfg.
Trial termination: Baclofen for Smoking Cessation in a Non-Psychiatric Population (clinicaltrials.gov) - Jan 3, 2013
P2, N=6, Terminated, Sponsor: Centre for Addiction and Mental Health
Active, not recruiting --> Completed Active, not recruiting --> Terminated; The study was terminated because of difficulties recruiting subjects.
- ||| Trial initiation date: ABT-436 for Alcohol Dependence (clinicaltrials.gov) - Jan 3, 2013
P2, N=148, Recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Active, not recruiting --> Terminated; The study was terminated because of difficulties recruiting subjects. Initiation date: Nov 2012 --> Mar 2013
- baclofen / Generic mfg.
Enrollment change: Baclofen for Smoking Cessation in a Non-Psychiatric Population (clinicaltrials.gov) - Jan 3, 2013
P2, N=6, Terminated, Sponsor: Centre for Addiction and Mental Health
Initiation date: Nov 2012 --> Mar 2013 N=45 --> 6
- ||| New P3 trial: Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone (clinicaltrials.gov) - Jan 2, 2013
P3, N=12, Active, not recruiting, Sponsor: New York State Psychiatric Institute
- Trial withdrawal: Computerized Alcohol Screening for Children and Adolescents (clinicaltrials.gov) - Jan 1, 2013
P=N/A, N=0, Withdrawn, Sponsor: Children's Hospital Boston
N=45 --> 6 Not yet recruiting --> Withdrawn
- Enrollment change: Computerized Alcohol Screening for Children and Adolescents (clinicaltrials.gov) - Jan 1, 2013
P=N/A, N=0, Withdrawn, Sponsor: Children's Hospital Boston
Not yet recruiting --> Withdrawn N=1000 --> 0
- Enrollment change: Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism (clinicaltrials.gov) - Jan 1, 2013
P=N/A, N=75, Completed, Sponsor: University of Texas Southwestern Medical Center
N=1000 --> 0 N=100 --> 75
- | Vycavert (10 mg hydrocodone bitartrate/325 mg acetaminophen) / Acura Pharma
New P2 trial: Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users (clinicaltrials.gov) - Jan 1, 2013
P2, N=40, Completed, Sponsor: Acura Pharmaceuticals Inc.
- Enrollment open: Validating NIAAA Screen Guide in YCMC (clinicaltrials.gov) - Jan 1, 2013
P=N/A, N=460, Recruiting, Sponsor: Children's Hospital Boston
N=100 --> 75 Not yet recruiting --> Recruiting
- metadoxine / Generic mfg.
Enrollment open: A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease (clinicaltrials.gov) - Jan 1, 2013
P2, N=83, Recruiting, Sponsor: Brown University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Enrollment closed: Intervention for Veterans With Depression, Substance Disorder, and Trauma (clinicaltrials.gov) - Jan 1, 2013
P0, N=130, Active, not recruiting, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Enrollment closed: Mentored Clinical Career Award in Adolescent Substance Abuse (clinicaltrials.gov) - Jan 1, 2013
P1/2, N=90, Active, not recruiting, Sponsor: Children's Hospital Boston
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial completion: Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism (clinicaltrials.gov) - Jan 1, 2013
P=N/A, N=75, Completed, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Active, not recruiting Recruiting --> Completed
- | dutasteride capsule / Generic mfg.
New P4 trial: Dutasteride Treatment for the Reduction of Heavy Drinking in Men (clinicaltrials.gov) - Dec 30, 2012
P4, N=160, Recruiting, Sponsor: University of Connecticut Health Center
- Trial completion: Impulsivity, Neural Deficits and Cocaine Addiction (clinicaltrials.gov) - Dec 30, 2012
P=N/A, N=90, Completed, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Completed Recruiting --> Completed
- mirtazapine / Generic mfg., quetiapine extended-release / Generic mfg.
Trial completion: A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency (clinicaltrials.gov) - Dec 26, 2012
P2, N=20, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- baclofen / Generic mfg.
Trial completion: A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking (clinicaltrials.gov) - Dec 26, 2012
P2, N=14, Completed, Sponsor: Brown University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- dutasteride capsule / Generic mfg.
Enrollment change: Dutasteride for the Reduction of Alcohol Use in Male Drinkers (clinicaltrials.gov) - Dec 23, 2012
P4, N=47, Completed, Sponsor: University of Connecticut Health Center
Active, not recruiting --> Completed N=60 --> 47
- dutasteride capsule / Generic mfg.
Trial completion: Dutasteride for the Reduction of Alcohol Use in Male Drinkers (clinicaltrials.gov) - Dec 23, 2012
P4, N=47, Completed, Sponsor: University of Connecticut Health Center
N=60 --> 47 Active, not recruiting --> Completed
- methadone / Generic mfg.
Trial initiation date: Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients (clinicaltrials.gov) - Dec 19, 2012
P=N/A, N=200, Recruiting, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Initiation date: May 2012 --> Dec 2012
- methadone / Generic mfg.
New P1 trial: The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome (clinicaltrials.gov) - Dec 19, 2012
P1, N=20, Active, not recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
- methadone / Generic mfg.
Enrollment open: Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients (clinicaltrials.gov) - Dec 19, 2012
P=N/A, N=200, Recruiting, Sponsor: Assistance Publique - H
Initiation date: May 2012 --> Dec 2012 Not yet recruiting --> Recruiting
- galantamine extended release / Generic mfg.
Enrollment change: Effect of Galantamine on Short-term Abstinence (clinicaltrials.gov) - Dec 18, 2012
P2, N=80, Recruiting, Sponsor: University of Pennsylvania
Not yet recruiting --> Recruiting N=24 --> 80
- Eyevinal (ibudilast) / MediciNova
Enrollment closed: Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal (clinicaltrials.gov) - Dec 17, 2012
P2a, N=30, Active, not recruiting, Sponsor: New York State Psychiatric Institute
N=24 --> 80 Completed --> Active, not recruiting
- | baclofen / Generic mfg.
New P2 trial: Baclofen for Treating Anxiety and Alcoholism (clinicaltrials.gov) - Dec 16, 2012
P2, N=132, Recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Enrollment closed: ADAPT: Adolescent Substance Abuse: Progressive Treatment (clinicaltrials.gov) - Dec 16, 2012
P1, N=140, Active, not recruiting, Sponsor: Oregon Research Institute
Completed --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial completion: CogEcig: Cognitive Functioning and Electronic Cigarette (clinicaltrials.gov) - Dec 16, 2012
P=N/A, N=20, Completed, Sponsor: Universita degli Studi di Catania
Recruiting --> Active, not recruiting Recruiting --> Completed
- baclofen / Generic mfg.
Enrollment open: Baclofen for Treating Anxiety and Alcoholism (clinicaltrials.gov) - Dec 14, 2012
P2, N=132, Recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial termination: Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS) (clinicaltrials.gov) - Dec 13, 2012
P0, N=99, Terminated, Sponsor: Texas Tech University Health Sciences Center
Not yet recruiting --> Recruiting Enrolling by invitation --> Terminated; This project was not a clinical trial requiring registration
- Enrollment change: Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS) (clinicaltrials.gov) - Dec 13, 2012
P0, N=99, Terminated, Sponsor: Texas Tech University Health Sciences Center
Enrolling by invitation --> Terminated; This project was not a clinical trial requiring registration N=125 --> 99
- Video: RAFT: Family Therapy Via Video Teleconference for Substance-Abusing Rural Adolescents (clinicaltrials.gov) - Dec 13, 2012
P=N/A, N=120, Recruiting, Sponsor: Oregon Research Institute
- ||||||| Trial completion: Highdose Nicotine Patch Therapy for Smokeless Tobacco Use (clinicaltrials.gov) - Dec 13, 2012
P2/3, N=52, Completed, Sponsor: Mayo Clinic
N=125 --> 99 Active, not recruiting --> Completed
- | memantine / Generic mfg.
Trial initiation date: NAMHS: Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (clinicaltrials.gov) - Dec 12, 2012
P2/3, N=82, Completed, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed Initiation date: Jun 2005 --> Jun 2008